Although germline or somatic genetic analyses were not performed in this case, it is noteworthy that SCLC is almost universally associated with inactivating mutations in the tumor protein p53 (TP53) and retinoblastoma 1 (RB1) genes, each present in over 90% of cases [4,18]. The gene discussed is TP53; the disease is small cell lung carcinoma.